Lipocine announces update on jury trial in patent infringement lawsuit against clarus therapeutics

Salt lake city, dec. 29, 2020 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that judge william c. bryson of the united states district court of delaware has postponed the february 8,...
LPCN Ratings Summary
LPCN Quant Ranking